The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Using patient-reported outcomes to assess the impact of germline genetic testing on prostate cancer patients.
 
Sarah M. Nielsen
Employment - InVitae
Stock and Other Ownership Interests - Invitae
Travel, Accommodations, Expenses - Invitae
 
Neal D. Shore
Employment - GenesisCare
Leadership - Alessa Therapeutics; Photocure
Consulting or Advisory Role - Abbvie; AIkido Pharma; Amgen; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Sanofi; CG Oncology; CG Oncology; Clarity Pharmaceuticals; Clovis Oncology; Dendreon; Exact Imaging; Exact Sciences; FerGene; Ferring; Foundation Medicine; Genesis Cancer Care; Genzyme; Guardant Health; ImmunityBio; Incyte; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myovant Sciences; Myriad Genetics; NGM Biopharmaceuticals; Nonagen Bioscience; Novartis; Nymox; Pacific Edge Biotechnology; Peerview; Pfizer; Phosphorus; Photocure; PlatformQ Health; Profound Medical; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Sesen Bio; Speciality Networks; Telix Pharmaceuticals; Tempus; Tolmar; Urogen pharma; Vaxiion; Vessi Medical
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Dendreon; Foundation Medicine; Guardant Health; Janssen; Merck; Pfizer
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow
Expert Testimony - Ferring
Other Relationship - Alessa Therapeutics; Photocure
 
Mukaram Gazi
Research Funding - Invitae
 
Christopher Michael Pieczonka
Employment - Associated Medical Professionals of New York
Leadership - Associated Medical Professionals of New York
Stock and Other Ownership Interests - US Urology Partners
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen; Merck; Myovant Sciences; Pfizer/Astellas; Sun Pharma
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Merck; Pfizer/Astellas; Sun Pharma; Sun Pharma; Tolmar
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Foundation Medicine; Janssen Oncology; Myovant Sciences; Pfizer; Sun Pharma
Research Funding - Advantagene; Astellas Pharma; AstraZeneca; Bayer; Dendreon; Janssen Oncology; Merck; Pfizer
 
Sean Heron
Research Funding - Invitae
 
David J Cahn
Research Funding - Invitae
 
Laurence Belkoff
Consulting or Advisory Role - Bayer; Immuno bio; Marius Pharmaceuticals
Research Funding - Invitae
 
Aaron D. Berger
Honoraria - AstraZeneca; Dendreon; Janssen Oncology; Myriad Genetics; Pfizer/Astellas
Consulting or Advisory Role - BK Ultrasound
Speakers' Bureau - Janssen Oncology; Myovant Sciences; Pfizer/Astellas
 
Brian Mazzarella
Employment - Convergent Genomics; Urology Austin
Leadership - Convergent Genomics
Stock and Other Ownership Interests - Convergent Genomics
Consulting or Advisory Role - Boston Scientific; Calyxo; IO Urology; Magforce; Neotract; UroDev Medical
Research Funding - Calyxo; Candel Therapeutics; Convergent Genomics; InVitae; Janssen; MDxHealth; Myovant Sciences; Neotract; Pfizer; Urotronic
Travel, Accommodations, Expenses - Convergent Genomics; Neotract
 
Joseph Veys
No Relationships to Disclose
 
David Morris
Stock and Other Ownership Interests - UROGPO
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Decipher Biosciences; Janssen Oncology; Myovant Sciences; Myriad Genetics; Pfizer/EMD Serono; Urogen pharma; UROGPO
Speakers' Bureau - Astellas Medivation; AstraZeneca; Clovis Oncology; Janssen; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca/Merck (Inst); Bayer (Inst); Clovis Oncology (Inst); Dendreon (Inst); Exelixis (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer/Astellas (Inst); Urogen pharma (Inst)
 
Richard Bevan-Thomas
Research Funding - Invitae
 
Alexander Engelman
Consulting or Advisory Role - Decipher Biosciences
Research Funding - Invitae
 
Paul Dato
Consulting or Advisory Role - Dendreon; Exact Imaging; Myovant Sciences
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Exact Imaging; Janssen; Myovant Sciences; Pfizer
Research Funding - Invitae
 
Robert Cornell
Research Funding - Invitae
 
David R Wise
Stock and Other Ownership Interests - Doximity
Honoraria - OncLive
Consulting or Advisory Role - Alphasights; Bayer; Foundation Medicine; Gerson Lehrman Group; Guidepoint Global; Janssen; LabCorp; Leap Therapeutics; Lilly; Myovant Sciences; Pfizer; Sanofi; silverlight
Travel, Accommodations, Expenses - Pfizer
 
Mary Kay Hardwick
Stock and Other Ownership Interests - Juva Life
Consulting or Advisory Role - Biofidelity; Invitae
 
Brandie Heald
Employment - InVitae
Stock and Other Ownership Interests - InVitae
 
Robert Luke Nussbaum
Employment - Invitae
Leadership - Invitae
Stock and Other Ownership Interests - Genome Medical; Invitae; Maze Therapeutics
Honoraria - Pfizer
Consulting or Advisory Role - Genome Medical; Maze Therapeutics; Pfizer
Patents, Royalties, Other Intellectual Property - Royalties on a patented mouse model for Parkinson disease held by the National Institutes of Health and the University of California San Francisco
 
Edward D. Esplin
Employment - Invitae
Stock and Other Ownership Interests - Invitae
Consulting or Advisory Role - Taproot Health Inc